Dudediligence.

Filana Therapeutics, Inc

FLNANASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$27.9MSep ’24−$27.6MDec ’24−$23.4MMar ’25−$44.2MJun ’25−$10.8MSep ’25−$12.5MDec ’25−$10.3MMar ’26−$8.6MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$32.9M−$80.0M−$106.0M−$141.4M−$95.4M
Net income−$32.4M−$76.2M−$97.2M−$24.3M−$91.0M
Operating cash flow−$30.2M−$77.5M−$82.0M−$116.9M−$32.3M
Free cash flow−$52.4M−$80.2M−$82.4M−$117.0M−$32.8M
Cash$233.4M$201.0M$121.1M$128.6M$95.5M
Shares outstanding40.0M41.7M42.2M48.2M48.3M